Results 71 to 80 of about 275 (120)

Pharmacogenomics of 17-alpha hydroxyprogesterone caproate for recurrent preterm birth prevention. [PDF]

Am J Obstet Gynecol, 2014
Manuck TA, Watkins WS, Moore B, Esplin MS, Varner MW, Jackson GM, Yandell M, Jorde L.   +7 more
europepmc   +1 more source

Prevention of preterm delivery with 17-hydroxyprogesterone caproate: pharmacologic considerations. [PDF]

Semin Perinatol, 2014
Feghali M, Venkataramanan R, Caritis S.
europepmc   +1 more source

Predictors of response to 17-alpha hydroxyprogesterone caproate for prevention of recurrent spontaneous preterm birth. [PDF]

Am J Obstet Gynecol, 2016
Manuck TA, Esplin MS, Biggio J, Bukowski R, Parry S, Zhang H, Huang H, Varner MW, Andrews W, Saade G, Sadovsky Y, Reddy UM, Ilekis J, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Genomics and Proteomics Network for Preterm Birth Research (GPN-PBR).   +13 more
europepmc   +1 more source

Progesterone blunts vascular endothelial cell secretion of endothelin-1 in response to placental ischemia. [PDF]

Am J Obstet Gynecol, 2013
Kiprono LV, Wallace K, Moseley J, Martin J, Lamarca B.   +4 more
europepmc   +1 more source

Profiles of 21-Carbon Steroids in 21-hydroxylase Deficiency.

J Clin Endocrinol Metab, 2015
Turcu AF, Rege J, Chomic R, Liu J, Nishimoto HK, Else T, Moraitis AG, Palapattu GS, Rainey WE, Auchus RJ.   +9 more
europepmc   +1 more source

Prevention of preterm birth by progestational agents: what are the molecular mechanisms? [PDF]

Am J Obstet Gynecol, 2013
Nold C, Maubert M, Anton L, Yellon S, Elovitz MA.   +4 more
europepmc   +1 more source

The effect of treatment with 17 alpha-hydroxyprogesterone caproate on changes in cervical length over time. [PDF]

Am J Obstet Gynecol, 2009
Durnwald CP, Lynch CD, Walker H, Iams JD.   +3 more
europepmc   +1 more source

17-α-Hydroxyprogesteron [PDF]

, 2019
openaire   +1 more source

Some of the next articles are maybe not open access.

Related searches:

On the Origin of 15α-Hydroxyprogesterone*

The Journal of Clinical Endocrinology & Metabolism, 1972
ABSTRACT Pools of urine obtained from subjects with varied endocrine status were analyzed for 15α-hydroxyprogesterone. The amounts of urinary 15α-hydroxyprogesterone isolated were 28–34 μg/day in the third trimester of pregnancy, 5–6 μg/day in the second trimester, 0–3 μg/day in the first trimester, 1–2 μg/day in patients with Cushing's syndrome and 0 ...
G, Giannopoulos, J, Bowman, S, Solomon
openaire   +2 more sources